1 Sep 2016 07:00
1 September 2016
Sphere Medical Holding plc
("Sphere Medical" or the "Company")
Notice of Interim Results
Sphere Medical Holding plc (AIM: SPHR.L), a leading provider of innovative monitoring and diagnostic devices for the critical care setting, will announce its interim results for the six months ended 30 June 2016 on Thursday 22 September 2016.
Dr. Wolfgang Rencken, Chief Executive Officer and Richard Wright, Chief Financial Officer, will host a presentation and conference call for analysts at 11:00 BST on the day of the results at 85 Gresham Street, London, EC2R 7HE.
- Ends -
For further information, please contact:
Sphere Medical Holding plc | Tel: +44 (0)1223 875 222 | |
Dr Wolfgang Rencken, Chief Executive Officer |
| |
Richard Wright, Chief Financial Officer |
| |
|
| |
Panmure Gordon | Tel: +44 (0) 20 7886 2500 | |
Freddy Crossley (Corporate Finance) |
| |
Duncan Monteith (Corporate Finance) |
| |
Tom Salvesen (Corporate Broking) |
| |
|
| |
Consilium Strategic Communications | Tel: +44 (0) 20 3709 5700 | |
Mary-Jane Elliott | spheremedical@consilium-comms.com | |
Chris Gardner |
| |
Ivar Milligan |
| |
Hendrik Thys |
| |
Notes for Editors
About Sphere Medical (AIM: SPHR.L)
Sphere Medical is an innovative point-of-care medical device company. Its ProximaTM platform measures blood gases, electrolytes and metabolites at the patient's bedside and aims to improve patient care and reduce health system costs. The device is currently sold directly to the critical care market via Sphere Medical's sales force in the UK, Germany, The Netherlands and Belgium. For further information, please visit www.spheremedical.com.